Weight-loss Drugs Could Boost US GDP by 1% in Coming Years, Goldman Says Weight-loss Drugs Could Boost US GDP by 1% in Coming Years, Goldman Says

The widespread use of powerful new weight-loss drugs in the United States could boost gross domestic product by 1% in the coming years as lower obesity-related complications...Reuters Health Information
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news